Middle East & Africa Rapid Test Kit Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), and End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others)

No. of Pages: 145    |    Report Code: BMIRE00030472    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East & Africa Rapid Test Kit Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Middle East & Africa Rapid Test Kit Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Middle East & Africa Rapid Test Kit Market – Key Market Dynamics

5.1 Growth Drivers
5.2 Market Opportunities
5.3 Future Trends
5.4 Impact of Drivers and Restraints

6. Middle East & Africa Rapid Test Kit Market Regional Analysis

6.1 Middle East & Africa Rapid Test Kit Market Overview
6.2 Middle East & Africa Rapid Test Kit Market Revenue 2020-2030 (US$ Million)
6.3 Middle East & Africa Rapid Test Kit Market Forecast Analysis

7. Middle East & Africa Rapid Test Kit Market Analysis – by Type

7.1 Rapid Antigen Testing
  • 7.1.1 Overview
  • 7.1.2 Rapid Antigen Testing: Middle East & Africa Rapid Test Kit Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Rapid Antibody Testing
  • 7.2.1 Overview
  • 7.2.2 Rapid Antibody Testing: Middle East & Africa Rapid Test Kit Market – Revenue and Forecast to 2031 (US$ Million)

8. Middle East & Africa Rapid Test Kit Market Analysis – by Product

8.1 Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit
  • 8.1.1 Overview
  • 8.1.2 Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit: Middle East & Africa Rapid Test Kit Market – Revenue and Forecast to 2030 (US$ Million)

9. Middle East & Africa Rapid Test Kit Market Analysis – by Application

9.1 Blood Glucose Testing
  • 9.1.1 Overview
  • 9.1.2 Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit: Middle East & Africa Rapid Test Kit Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Infectious Disease Testing
  • 9.2.1 Overview
  • 9.2.2 Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit: Middle East & Africa Rapid Test Kit Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Pregnancy and Fertility
  • 9.3.1 Overview
  • 9.3.2 Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit: Middle East & Africa Rapid Test Kit Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Cardiometabolic Testing
  • 9.4.1 Overview
  • 9.4.2 Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit: Middle East & Africa Rapid Test Kit Market – Revenue and Forecast to 2030 (US$ Million)

10. Middle East & Africa Rapid Test Kit Market – Middle East and Africa Analysis

10.1 Middle East and Africa
  • 10.1.1 Middle East & Africa Rapid Test Kit Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 10.1.1.1 Middle East & Africa Rapid Test Kit Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 South Africa: Middle East & Africa Rapid Test Kit Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.1.1 South Africa: Middle East & Africa Rapid Test Kit Market Breakdown, by Type
    • 10.1.1.1.2 South Africa: Middle East & Africa Rapid Test Kit Market Breakdown, by Product
    • 10.1.1.1.3 South Africa: Middle East & Africa Rapid Test Kit Market Breakdown, by Application
  • 10.1.1.2 Saudi Arabia: Middle East & Africa Rapid Test Kit Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.2.1 Saudi Arabia: Middle East & Africa Rapid Test Kit Market Breakdown, by Type
    • 10.1.1.2.2 Saudi Arabia: Middle East & Africa Rapid Test Kit Market Breakdown, by Product
    • 10.1.1.2.3 Saudi Arabia: Middle East & Africa Rapid Test Kit Market Breakdown, by Application
  • 10.1.1.3 UAE: Middle East & Africa Rapid Test Kit Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.3.1 UAE: Middle East & Africa Rapid Test Kit Market Breakdown, by Type
    • 10.1.1.3.2 UAE: Middle East & Africa Rapid Test Kit Market Breakdown, by Product
    • 10.1.1.3.3 UAE: Middle East & Africa Rapid Test Kit Market Breakdown, by Application
  • 10.1.1.4 Rest of Middle East and Africa: Middle East & Africa Rapid Test Kit Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.4.1 Rest of Middle East and Africa: Middle East & Africa Rapid Test Kit Market Breakdown, by Type
    • 10.1.1.4.2 Rest of Middle East and Africa: Middle East & Africa Rapid Test Kit Market Breakdown, by Product
    • 10.1.1.4.3 Rest of Middle East and Africa: Middle East & Africa Rapid Test Kit Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Middle East & Africa Rapid Test Kit Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 F. Hoffmann-La Roche Ltd
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Becton Dickinson and Co
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 ARKRAY Inc
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Fujirebio Europe NV
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 bioMerieux SA
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Cepheid
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Meril Life Sciences Pvt Ltd
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 QIAGEN NV
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Guangzhou Wondfo Biotech Co Ltd
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Abbott Laboratories
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments
13.11 Bio-Rad Laboratories Inc
  • 13.11.1 Key Facts
  • 13.11.2 Business Description
  • 13.11.3 Products and Services
  • 13.11.4 Financial Overview
  • 13.11.5 SWOT Analysis
  • 13.11.6 Key Developments
13.12 Hologic Inc
  • 13.12.1 Key Facts
  • 13.12.2 Business Description
  • 13.12.3 Products and Services
  • 13.12.4 Financial Overview
  • 13.12.5 SWOT Analysis
  • 13.12.6 Key Developments
13.13 Premier Medical Corp Pvt Ltd
  • 13.13.1 Key Facts
  • 13.13.2 Business Description
  • 13.13.3 Products and Services
  • 13.13.4 Financial Overview
  • 13.13.5 SWOT Analysis
  • 13.13.6 Key Developments
13.14 DiaSorin SpA
  • 13.14.1 Key Facts
  • 13.14.2 Business Description
  • 13.14.3 Products and Services
  • 13.14.4 Financial Overview
  • 13.14.5 SWOT Analysis
  • 13.14.6 Key Developments
13.15 Beckman Coulter Inc
  • 13.15.1 Key Facts
  • 13.15.2 Business Description
  • 13.15.3 Products and Services
  • 13.15.4 Financial Overview
  • 13.15.5 SWOT Analysis
  • 13.15.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - M Market

1. F. Hoffmann-La Roche Ltd
2. Becton Dickinson and Co
3. ARKRAY Inc
4. Fujirebio Europe NV
5. bioMerieux SA
6. Cepheid
7. Meril Life Sciences Pvt Ltd
8. QIAGEN NV
9. Guangzhou Wondfo Biotech Co Ltd
10. Abbott Laboratories
11. Bio-Rad Laboratories Inc
12. Hologic Inc
13. Premier Medical Corp Pvt Ltd
14. DiaSorin SpA
15. Beckman Coulter Inc

middle-east-and-africa-rapid-test-kit-market